Skorping, Denmark

Lars Pilegaard Thomsen

This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignees: Aalborg University, Roche Diagnostics Gmbh. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lars Pilegaard Thomsen: Innovator in Tissue Hypoxia Measurement

Introduction

Lars Pilegaard Thomsen is a notable inventor based in Skørping, Denmark. He has made significant contributions to the field of medical diagnostics, particularly in the identification and quantification of tissue hypoxia. His innovative approach has the potential to enhance patient care and treatment outcomes.

Latest Patents

Lars holds a patent titled "Identification and quantification of the degree of tissue hypoxia." This invention relates to a method for identifying tissue hypoxia through measurements of acid-base and oxygenation status from venous and/or arterial blood. His work in this area is crucial for advancing medical diagnostics.

Career Highlights

Throughout his career, Lars has worked with prominent organizations, including Roche Diagnostics A/S and Aalborg Universitet. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to advancements in medical technology.

Collaborations

Lars has collaborated with talented individuals such as Bruno Graversen and Lisha Shastri. These partnerships have fostered a creative environment that has led to significant advancements in their respective fields.

Conclusion

Lars Pilegaard Thomsen is a distinguished inventor whose work in tissue hypoxia measurement exemplifies innovation in medical diagnostics. His contributions are paving the way for improved healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…